scispace - formally typeset
G

Giordano Caponigro

Researcher at Novartis

Publications -  68
Citations -  13761

Giordano Caponigro is an academic researcher from Novartis. The author has contributed to research in topics: Cancer & MAPK/ERK pathway. The author has an hindex of 26, co-authored 64 publications receiving 11082 citations. Previous affiliations of Giordano Caponigro include University of Arizona & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

TL;DR: The results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents and the generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.
Journal ArticleDOI

Next-generation characterization of the Cancer Cell Line Encyclopedia

Mahmoud Ghandi, +79 more
- 08 May 2019 - 
TL;DR: The original Cancer Cell Line Encyclopedia is expanded with deeper characterization of over 1,000 cell lines, including genomic, transcriptomic, and proteomic data, and integration with drug-sensitivity and gene-dependency data, which reveals potential targets for cancer drugs and associated biomarkers.
Journal ArticleDOI

Single-vector inducible lentiviral RNAi system for oncology target validation.

TL;DR: The versatile and robust inducible lentiviral RNAi system reported herein can serve as a powerful tool to rapidly reveal tumor cell dependence.
Journal ArticleDOI

Erratum: Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity (Nature (2012) 483 7391 (603-607))

TL;DR: Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A. Golub, Michael P. Morais, Jodi Meltzer, Judit Jané-Valbuena, Felipa A. Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying K. Yu